| Good | Moderate | None | |
|---|---|---|---|
| Pts. evaluated | 110 | 112 | 205 |
| Placebo DAS28 Response | 5.7% | 15.9% | 78.4% |
| Infliximab DAS28 Response | 30.9% | 28.9% | 40.2% |
| Mean ± SD | $3,836 ± $2,893 | $5,613 ± $6,640 | $13,125 ± $29,119 |
| Median | $2,965 | $3,386 | $5,530 |
| Interquartile range | ($1,960,$4,856) | ($2,170,$6,130) | ($2,889,$10,501) |
| Range | ($433,$16,717) | ($141,$39,610) | ($226,$350,138) |